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Identification of the Active Form of Endothelial Lipase, a Homodimer in a Headto-Tail Conformation
Abstract
Endothelial lipase (EL) is a member of a subfamily of lipases that act on triglycerides and phospholipids
in plasma lipoproteins, which also includes lipoprotein lipase and hepatic lipase. EL has a tropism for high
density lipoprotein, and its level of phospholipase activity is similar to its level of triglyceride lipase
activity. Inhibition or loss-of-function of EL in mice results in an increase in high density lipoprotein
cholesterol, making it a potential therapeutic target. Although hepatic lipase and lipoprotein lipase have
been shown to function as homodimers, the active form of EL is not known. In these studies, the size and
conformation of the active form of EL were determined. Immunoprecipitation experiments suggested
oligomerization. Ultracentrifugation experiments showed that the active form of EL had a molecular
weight higher than the molecular weight of a simple monomer but less than a dimer. A construct
encoding a covalent head-to-tail homodimer of EL (EL-EL) was expressed and had similar lipolytic activity
to EL. The functional molecular weights determined by radiation inactivation were similar for EL and the
covalent homodimer EL-EL. We previously showed that EL could be cleaved by proprotein convertases,
such as PC5, resulting in loss of activity. In cells overexpressing PC5, the covalent homodimeric EL-EL
appeared to be more stable, with reduced cleavage and conserved lipolytic activity. A comparative model
obtained using other lipase structures suggests a structure for the head-to-tail EL homodimer that is
consistent with the experimental findings. These data confirm the hypothesis that EL is active as a
homodimer in head-to-tail conformation.
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contribute to lipoprotein catabolism in the plasma compartment. They are all secreted proteins that bind to heparan sulfate
proteoglycans on the luminal side of endothelial cells where
they interact with their lipoprotein substrates. They have different specificities for lipoproteins, and all hydrolyze triglycerides and phosphatidylcholine at the sn-1 position, albeit with
widely differing efficiencies (1). The preferred lipoprotein substrates for LPL are the triglyceride-rich lipoproteins, chylomicrons, and very low density lipoproteins; the triglyceride lipase
activity of LPL is more than 100-fold greater than its phospholipase activity. The primary lipoprotein substrates for HL are
chylomicron remnants, intermediate density lipoproteins, and
large triglyceridase-enriched HDL; its triglyceride lipase activity is about 20-fold higher than its phospholipase activity. EL is
much more active on HDL, and its phospholipase activity is
quite similar to its triglyceride lipase activity.
These three lipolytic enzymes share a number of structural
features. By analogy to the crystal structure of pancreatic lipase
(2), another member of the triglyceride lipase family, each has a
clearly defined N-terminal and C-terminal structural domain,
joined by a hinge region. They are all serine esterases with a
catalytic triad of serine, aspartic acid, and histidine located in
the N-terminal domain. The catalytic triad is covered by a lid
domain that contributes to the preference for either triglyceride or phospholipid substrates (3– 6). The C-terminal domain
contributes to lipid binding and determines the preferences for
binding to lipoproteins (7–12). The N-terminal portion of the
EL molecule contains the active site of the enzyme. However,
when this portion of the molecule is expressed without the
C-terminal domain, it lacks enzymatic activity against phospholipid (13), triglyceride, and the more soluble micellar substrate tributyrin.4 Thus, the presence of the C-terminal domain
is necessary for activity. All three enzymes are glycosylated to
varying degrees, and two of the glycosylation sites (one each in
the N- and C-terminal domains) are common to all three
enzymes (14, 15). All three enzymes are also heparin-binding
proteins, and regions that contribute to heparin binding are
found in both the N- and C-terminal domains (16 –18).
EL and, to a lesser extent, LPL are subject to proteolytic
cleavage by proprotein convertases at a prototypical RXKR site
in the hinge region, but HL lacks the site and is not cleaved (19,
4

N. Griffon, J. M. Glick, and D. J. Rader, unpublished observations.
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Endothelial lipase (EL) is a member of a subfamily of lipases
that act on triglycerides and phospholipids in plasma lipoproteins, which also includes lipoprotein lipase and hepatic lipase.
EL has a tropism for high density lipoprotein, and its level of
phospholipase activity is similar to its level of triglyceride lipase
activity. Inhibition or loss-of-function of EL in mice results in an
increase in high density lipoprotein cholesterol, making it a
potential therapeutic target. Although hepatic lipase and
lipoprotein lipase have been shown to function as homodimers,
the active form of EL is not known. In these studies, the size and
conformation of the active form of EL were determined. Immunoprecipitation experiments suggested oligomerization. Ultracentrifugation experiments showed that the active form of EL
had a molecular weight higher than the molecular weight of a
simple monomer but less than a dimer. A construct encoding a
covalent head-to-tail homodimer of EL (EL-EL) was expressed
and had similar lipolytic activity to EL. The functional molecular weights determined by radiation inactivation were similar for EL and the covalent homodimer EL-EL. We previously
showed that EL could be cleaved by proprotein convertases,
such as PC5, resulting in loss of activity. In cells overexpressing PC5, the covalent homodimeric EL-EL appeared to be
more stable, with reduced cleavage and conserved lipolytic
activity. A comparative model obtained using other lipase
structures suggests a structure for the head-to-tail EL
homodimer that is consistent with the experimental findings.
These data confirm the hypothesis that EL is active as a
homodimer in head-to-tail conformation.

Endothelial Lipase Functions as a Head-to-Tail Dimer

FIGURE 1. Schematic diagram of EL-EL construct. Shown is a schematic
diagram representing EL-EL, the homodimer of EL in a head-to-tail conformation. A short hinge (linker) of 8 amino acid residues (GSIEGRLE) joined the two
monomeric subunits of EL using overlap extension PCR. EL-EL contained
sequences coding for the signal peptide (SP) of EL, the mature EL protein, the
8 amino acid-peptide linker containing a factor Xa site, and another mature EL
protein. Each monomeric subunit of mature EL protein has an N-terminal
domain (N) and a C-terminal domain (C). To allow comparison of the levels of
expression of the dimeric construct (EL-EL) and wild-type EL, we constructed
C-terminal myc-His-tagged proteins.

EXPERIMENTAL PROCEDURES
Construction of a Head-to-Tail Dimer of EL (EL-EL)—We
used PCR to engineer a head-to-tail dimer of two monomeric
subunits of EL (EL-EL) in an approach similar to that of Wong
et al. (28) for LPL using the same short hinge of 8 amino acids
(GSIEGRLE) to create the head-to-tail dimer of EL (Fig. 1).
Two cDNAs of human EL were amplified separately by
PCR. Each cDNA contained engineered restriction sites to
facilitate assembly and subcloning into the expression plasmid pcDNA3.1/myc-His(⫺)A (Invitrogen). The sense primer
of the first cDNA of EL (5⬘-ACGTTCTAGAGGCAGGATGAGCAACTCCG-3⬘) contained an XbaI restriction site and the
first 13 coding nucleotides of the EL cDNA. The antisense
primer of the first cDNA of EL (5⬘-CGCTCTCGAGACGACCTTCGATGGATCCGGGAAGCTCCACAGTGGGAC-3⬘)
contained the last 20 coding nucleotides of the EL cDNA, a
factor Xa site (coding for 8 amino acids, GSIEGRLE), and an
XhoI restriction site. The sense primer of the second cDNA of
EL (5⬘-GCGTCTCGAGAGCCCCGTACCTTTTGGTC-3⬘)
contained an XhoI restriction site and the first 19 coding nucleotides of the mature EL protein. The antisense primer of the
second cDNA of EL (5⬘-TGACAAGCTTTCAGGGAAGCTCCACAGTGGGAC-3⬘) contained the last 23 coding nucleotides
of the EL cDNA and a HindIII restriction site. These two PCR
products were purified, digested using XbaI, XhoI, and HindIII
restriction enzymes, and then ligated using T4 ligase from a
rapid ligation kit (Roche Applied Science). The final product
contained sequences coding for the signal peptide of EL, the
mature EL protein, an 8-amino acid-peptide linker containing a
factor Xa site, and another mature EL protein (Fig. 1). To allow
comparison of the levels of expression of the dimeric construct
(EL-EL) and wild-type EL, we constructed C-terminal myc-Histagged proteins by inserting the full-length cDNA into
pcDNA3.1/myc-His(⫺)A plasmid expression vector (Invitrogen). The construct was sequenced to confirm accuracy.
AUGUST 28, 2009 • VOLUME 284 • NUMBER 35
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20). The catalytically active forms of both LPL and HL have
been shown to be homodimers (18, 21–27), and in the case of
LPL, the orientation of the subunits of the dimer has been
shown to be head-to-tail (28 –30). The present study tested the
hypothesis that EL also functions as a head-to-tail dimer.

Cell Culture and Transfections—HEK293 cells and sublines
stably expressing profurin or PC5a were maintained in Dulbecco’s modified Eagle’s medium, 10% fetal bovine serum, and 1⫻
antibiotic/antimycotic supplement (Invitrogen). The cells were
transfected with EL constructs using LipofectamineTM reagent
(Invitrogen). Twenty four h after transfection, the medium was
replaced with Dulbecco’s modified Eagle’s medium containing
10 units/ml heparin (Sigma) and incubated for another 24 h.
Thirty min prior to harvesting this conditioned medium, more
heparin was added to the medium, bringing the final concentration of heparin to 20 units/ml. Conditioned media were collected, subjected to low speed centrifugation, and frozen in aliquots at ⫺80 °C. For some experiments where high enzyme
activity was required (sucrose gradients and radiation inactivation), the conditioned medium was concentrated 5-fold using
an Amicon ultracentrifugal filtration device (30,000 Mr cutoff)
(Millipore).
Western Blotting—The levels of protein expression of wildtype EL and EL-EL were estimated by Western blot. For each
experiment, we used conditioned medium from cells transfected to express green fluorescent protein (GFP) as a negative
control. Ten l of conditioned media were resolved on 10%
BisTris or 7% Tris acetate SDS-PAGE (Invitrogen) and transferred to Hybond ECL nitrocellulose membrane (Amersham
Biosciences). Proteins were detected using either a polyclonal
rabbit anti-human EL primary antibody specific for a peptide in
the N-terminal region or a monoclonal mouse anti-Myc primary antibody (clone 9E10) and a horseradish peroxidase-conjugated secondary antibody (Jackson ImmunoResearch).
Co-immunoprecipitation—Conditioned media from HEK293
cells transfected with GFP and co-transfected with EL-myc-His
and EL-FLAG or a 1:1 mixture of media from HEK293 cells,
which had been transfected with EL-myc-His or EL-FLAG,
were incubated with mouse (or rabbit) anti-Myc (Abcam) or
mouse anti-FLAG IgG (Sigma) at 4 °C in the presence of 0.1%
Triton X-100 (Fisher) for 2 h. Protein G magnetic beads (New
England Biolabs) were added to each sample, and samples were
incubated overnight at 4 °C. Supernatant and pellet were separated after centrifuging for 10 min at 10,000 ⫻ g, 4 °C. Pellets
were washed three times with phosphate-buffered saline and
eluted from the beads with 4⫻ loading buffer and 10⫻ dithiothreitol (Invitrogen). Western blot analysis of samples was performed using a rabbit anti-EL antibody or a rabbit anti-Myc
(Biovision) or a mouse anti-FLAG antibody (HRP conjugate,
Sigma).
Sucrose Gradient Ultracentrifugation—Sucrose gradients were
prepared as described (27). Briefly, 5–20% sucrose gradients
containing 50 mM ammonium hydroxide, pH 8.1, were prepared. Glucose-6-phosphate dehydrogenase (G6PDH) (110
kDa) was added to each sample to serve as an internal standard.
Cytochrome c (12.5 kDa), ovalbumin (45 kDa), malate dehydrogenase (74 kDa), and catalase (240 kDa) were centrifuged in two
separate tubes and served as external standards. After centrifugation (22 h at 200,000 ⫻ g at 4 °C), 600-l fractions were
collected and assayed for enzyme activity and protein concentration. The protein concentration was determined in each
fraction of external standards using a commercially available kit
(BCA protein assay kit, Pierce).
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code 1N8S), H. sapiens pancreatic lipase and S. scrofa colipase complex inhibited by undecane phosphonate methyl
ester (PDB accession code 1LPB), and Equus caballus pancreatic lipase (PDB accession code 1HPL). Multiple
sequence alignments with the human EL protein sequence
and those of the aforementioned three protein structures
were generated by ClustalW (EMBL-EBI) using default
parameter settings (38). The human EL sequence has 27%
identity to human pancreatic lipase and 25% identity to
horse pancreatic lipase. These identical residues located
throughout the crystal structures of the pancreatic lipases
served as anchors to guide the modeling of human endothelial lipase. The EL sequence contains 37 residues at the C terminus that were not used in the modeling process because there
is no significant sequence homology to the other template
lipase structures in this region. The human EL models were
evaluated using the discrete optimized protein energy algorithms of MODELLER version 9v1 (39). To investigate the
model structure in the context of a homodimer, the best scoring
human endothelial lipase monomer models were structurally
aligned to each monomer of the horse pancreatic lipase
homodimer using MacPyMOL version 0.96.

RESULTS
EL Is a Dimer That Forms Intracellularly—To understand
the intermolecular interaction of EL, we used two EL constructs, one encoding a FLAG tag and the other a myc-His tag at
the C terminus. Neither tag had any effect on EL lipolytic activity (data not shown). Constructs encoding EL-myc-His and ELFLAG were co-transfected in HEK293 cells. Conditioned
medium was harvested and subjected to immunoprecipitation
using an anti-Myc antibody to precipitate any Myc-containing
proteins. The precipitated proteins were examined by Western
blotting using an anti-FLAG antibody as well as an anti-EL antibody specific for a peptide in the N-terminal domain. No
immunoreactive bands were detected in conditioned medium
from cells transfected with a construct encoding GFP. As
shown in Fig. 2, when constructs encoding EL-myc-His and
EL-FLAG were co-transfected in HEK293 cells, the anti-FLAG
antibody detected FLAG-tagged EL in the material that had
been immunoprecipitated with anti-Myc antibody, indicating
that there was interaction between EL-FLAG and EL-myc-His
proteins, consistent with dimer formation. When conditioned
medium containing EL-FLAG was mixed with conditioned
medium containing EL-myc-His and subsequently immunoprecipitated, no interaction was detected, suggesting that the
association between monomeric units occurs intracellularly
and that the association between subunits is very strong.
Active EL Is Larger than a Monomer and Consistent with
Partially Cleaved Dimer—Sucrose gradient centrifugation of
conditioned medium from cells expressing wild-type EL was
used to determine the size of the functional unit of EL. The
major peak of the triglyceride lipase activity of EL appeared as a
distinct species somewhat smaller than G6PDH (which has a
molecular weight of 110,000) as shown in Fig. 3A. A linear relationship was observed when the molecular weights of standard
proteins versus sucrose concentrations were plotted (Fig. 3B).
The relative molecular weight of the EL functional unit was
VOLUME 284 • NUMBER 35 • AUGUST 28, 2009
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Radiation Inactivation—Conditioned medium containing
partially cleaved myc-His-tagged EL was prepared by transfection in HEK293 cells as described above. Media containing
either uncleaved myc-His-tagged wild-type EL or uncleaved
myc-His-tagged EL-EL dimer were prepared in a similar manner by transfection in HEK293 cells that stably express profurin.
Apotransferrin (2 mg/ml, Sigma) and G6PDH (4 units/ml,
Sigma) were added to the media. Samples of these media (0.55
ml) were placed in glass vials, quick frozen, sealed, and stored at
⫺80 °C. Vials were shipped and returned on dry ice. Irradiations were performed with a linear electron accelerator at the
Armed Forces Radiobiology Research Institute, Bethesda, or at
the National Institute of Standards and Technology, Gaithersburg, MD. Frozen samples were irradiated at ⫺135 °C with a
beam of 13-MeV electrons as described (31). Two aliquots not
irradiated served as the zero dose controls. Radiation dose was
determined with thermoluminescent or alanine dosimeters.
Irradiated frozen samples were stored at ⫺80 °C until assayed
for triglyceride lipase activity. The activity (A) at each dose was
divided by the activity at zero dose (A0) to determine the fractional residual activity at each dose. For each enzyme preparation, the natural logarithm of the fraction remaining was plotted as a function of radiation dose. The slopes of these lines
were determined by linear regression (GraphPad Prizm) and
were used to calculate molecular mass as described previously
(31). The slopes for the inactivation of G6PDH were identical in
all sample sets.
Triglyceride Lipase and Phospholipase Assays—Emulsions of
triolein or dipalmitoylphosphatidylcholine were used to measure triglyceride lipase or phospholipase activity, respectively (1,
32, 33). For the triglyceride lipase assay, the emulsion contained
triolein and egg phosphatidylcholine containing glycerol
tri[9,10-3H]oleate stabilized with glycerol. For the phospholipase assay, a similar glycerol-stabilized emulsion was used that
contained radiolabeled phospholipids ([14C]dipalmitoylphosphatidylcholine) and cholesteryl oleate as the neutral lipid core.
Samples were incubated for 15 min at 37 °C. All enzyme activities are reported as nanomoles of free fatty acid liberated/h-ml
conditioned medium as source of enzyme. All assays were done
in triplicate.
Other Enzyme Assays—Malate dehydrogenase activity was
measured by incubating 2 l of sample with 294 l of substrate
made of 367.4 M oxaloacetate and 204 M NADH in 40 mM
Tris-H2SO4, pH 7.4, at 25 °C. The decrease in absorbance was
monitored at 340 nm. G6PDH activity was measured by incubating 5 l of sample in a final volume of 200 l containing 50
mM Tris-HCl, pH 7.8, 3 mM MgCl2, 0.2 mM NADP, and 3.3 mM
glucose 6-phosphate for 15 min at 25 °C and monitoring the
increase in absorbance at 340 nm.
Comparative Protein Structure Modeling Methods—The
human EL models were generated using the molecular modeling suite MODELLER version 8v1 (Accelrys Discovery Studio,
San Diego) and evaluated with MODELLER versions 8v1 and
9v1 (34 –37). As input for the modeling algorithm, the human
EL protein sequence, NCBI protein data base accession code
NP_006024.1, was aligned to the following lipase structures
obtained from the Protein Data Bank: Homo sapiens pancreatic lipase and Sus scrofa co-lipase complex (PDB accession

Endothelial Lipase Functions as a Head-to-Tail Dimer
approach similar to that of Wong et al. (28) for LPL. The final
cDNA product contained sequences coding for the signal peptide of EL, the mature EL protein, the 8-amino acid peptide
linker followed by another mature EL protein, and a C-terminal
myc-His tag (Fig. 1). The expression of the dimeric construct
(EL-EL) was compared with wild-type EL, which was also mycHis-tagged. Western blots of conditioned media of transiently
transfected HEK293 cells using an antibody against the Myc tag
as primary antibody (Fig. 4B) showed a band corresponding to a
full-length monomer (68 kDa) in the case of wild-type EL and a
dimer (136 kDa) in the case of EL-EL, as well as the cleavage
products that are myc-His-tagged. Although dimeric forms are
not always present in Western blots for wild-type EL, a dimeric
form and partially cleaved dimer are also visible in the wild-type
EL lane. In the Western blot of the same media using an antibody against EL as primary antibody (Fig. 4C), we observed the
full-length monomer of wild-type EL (68 kDa) and the fulllength dimer of EL-EL (136 kDa), and as expected some cleavage products (20). Interestingly, in the case of EL-EL we
detected cleavage products of intermediate size between a
monomer and a dimer corresponding to a monomer plus the
N-terminal domain (108 kDa) and a monomer plus the C-terminal domain (96 kDa).
We compared the enzymatic activity of wild-type EL and
EL-EL using lipid emulsions of triglyceride and phospholipid to
measure triglyceride lipase and phospholipase activity, respectively. The EL-EL dimer showed both triglyceride lipase and
phospholipase activities. For each transfection, we consistently
measured more lipase activity (both triglyceride lipase and
phospholipase) in EL-EL despite the protein band in the respective Western blot often appearing of similar or lesser intensity
FIGURE 2. EL protein forms immunoprecipitable complex during secretion but not after secretion. HEK293 conditioned media were prepared as than the band of the full-length wild-type EL (Fig. 4B). The ratio
follows. Lanes 1 and 4 are from cells expressing GFP; lanes 2 and 5 are mixtures of the triglyceride lipase activity to phospholipase activity (trigof media from cells separately transfected with either EL-myc-His or EL-FLAG;
lanes 3, 6, and 7 are media from cells co-transfected with EL-myc-His and lyceridase/phospholipase ratio) reflects the substrate specificEL-FLAG. Western blots (WB) show supernatants (lanes 1–3) and pellets (lanes ity of the enzyme and was not significantly different for EL-EL
4 – 6) after immunoprecipitation (IP) with mouse anti-Myc from samples as (1.46 ⫾ 0.57) than for EL (1.56 ⫾ 0.24). Thus the EL protein in
indicated. Lane 7 shows the pellet after immunoprecipitation with mouse
anti-FLAG from conditioned media from HEK293 cells co-transfected with a dimeric head-to-tail conformation (EL-EL) was active both as
EL-myc-His and EL-FLAG. These Western blots used either an antibody a triglyceride lipase and phospholipase. These data are consistagainst an EL peptide, FLAG tag, or Myc tag for detection. F indicates the
full-length monomer size of EL; N indicates the N-terminal domain of EL, and ent with a model that EL is active as dimer in a head-to-tail
conformation.
C indicates the C-terminal domain of EL.
Intermediate Oligomeric Forms of
EL Are Enzymatically Active—EL is
active as a dimer in a head-to-tail
conformation, but other intermediate forms could potentially also be
active provided that an intact active
site is present and preserved. To test
that hypothesis, we expressed wildtype EL and EL-EL in HEK293 cells
under conditions promoting different levels of cleavage. We used
HEK293 cells stably expressing proFIGURE 3. A, sucrose gradient centrifugation of wild-type EL. After 5–20% sucrose gradient ultracentrifugation, furin, which has been reported to
samples were collected. Each fraction was tested for TG lipase activity (⽧) and G6PDH activity (f). The perprevent EL cleavage, or expressing
centage of sucrose was also measured in each fraction collected. B, molecular weight of wild-type EL determined by ultracentrifugation. The molecular standards used in this experiment were cytochrome c (12.5 kDa), PC5a which has been reported to
ovalbumin (45 kDa), malate dehydrogenase (74 kDa), G6PDH (114 kDa), and catalase (240 kDa). After centrifu- fully cleave EL (20). Fig. 5 shows that
gation (22 h at 200,000 ⫻ g at 4 °C), fractions were collected and assayed for enzyme activity and protein
concentration. There is a linear relationship between the molecular weights of standard proteins and the indeed more full-length EL and
sucrose percentage.
EL-EL dimer were present in the

94,500, considerably smaller than a dimer of full-length monomers (136 kDa) and larger than a monomer (68 kDa). This functional size is most consistent with partially cleaved forms where
part of the cleaved monomer remains associated with an
uncleaved monomer (Fig. 4A).
A Covalent Head-to-Tail EL Dimer Is Highly Active—We
engineered a construct encoding a covalent head-to-tail dimer
of two monomeric subunits of EL (EL-EL) joined by a short
hinge of eight amino acid residues (GSIEGRLE) using an
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cleavage in HEK293 cells and in the
absence or presence of PC5a in
comparison with wild-type EL.
These data support the concept that
the oligomeric state of EL is dimeric
and that the linker hinge in the EL-EL
protein stabilizes the enzyme, making
it less prone to inactivating enzymatic
cleavage by enzymes of the proprotein convertase family such as PC5a.
The linker hinge also ensures that the
N-terminal and C-terminal domains
remain attached and presumably preserve an active site.
We measured the triglyceride
lipase and phospholipase activity of
FIGURE 4. A, cleavage products of EL monomer and EL dimer. A schematic diagram is shown of all the potential wild-type EL and EL-EL in these three
intermediate forms of EL monomer and EL dimer induced by the proteolytic cleavage of EL by proprotein experimental conditions (Table 1). In
convertases. All the possible forms varying from uncleaved to partially cleaved and fully cleaved in the case of the case of EL, both the triglyceride
EL monomer and EL dimer are represented. The relative molecular mass of each of these forms in kDa is shown.
B, Western blot of EL and EL-EL detected by an antibody against Myc tag. Expression in HEK293 conditioned lipase and phospholipase activity of
media of Myc-tagged EL and EL-EL was detected by Western blot using a mouse anti-Myc monoclonal antibody wild-type EL decreased as the amount
and HRP-conjugated secondary antibody. Schematic diagrams of the different forms of EL detected by the
anti-Myc antibody are shown. C, Western blot of EL and EL-EL detected by an antibody against EL. Expression of cleavage increased (Fig. 5 and Table
in HEK293 conditioned media of Myc-tagged EL and EL-EL was detected by Western blot using a rabbit anti- 1). Similar results were observed in
human EL polyclonal antibody and HRP-conjugated secondary antibody. Schematic diagrams of the different the case of EL-EL, where both the
forms of EL as detected by the anti-EL antibody are shown.
triglyceride lipase and phospholipase activity of EL-EL decreased as
the amount of cleavage increased (Fig. 5 and Table 1). EL-EL
differed from wild-type EL only in the extent of the effect.
Indeed, EL-EL only partially lost activity in the presence of
PC5a, whereas wild-type EL was more drastically affected. Our
activity data (triglyceride lipase and phospholipase) associated
with the mass indicated that as less protein was cleaved in the
case of EL-EL compared with wild-type EL, more lipolytic enzymatic activity remained (Fig. 5 and Table 1). These data indicated that not only is EL active as a homodimer but that the
cleavage of EL results in a loss of activity and the partially or
wholly cleaved forms of EL are less active or inactive.
Comparison of the Molecular Mass of Uncleaved Wild-type
EL and Uncleaved Dimeric EL—The functional size of EL was
examined using radiation inactivation. Conditioned medium
was prepared from cells expressing myc-His-tagged wild-type
EL that was partially cleaved. The same construct was transfected in cells expressing profurin to produce EL that was
uncleaved, as was the myc-His-tagged head-to-tail construct
EL-EL, to produce the covalently linked dimer, also uncleaved.
As shown in Fig. 6, all three preparations gave single exponential decays as a function of radiation dose. Unlike the sucrose
density analysis, radiation inactivation is not influenced by glyFIGURE 5. Western blots of EL and EL-EL under conditions promoting differ- cosylation. The inactivation is a function only of the protein
ent levels of cleavage. The level of protein expression in HEK293 conditioned component of the enzyme. The predicted protein mass of a
media was detected by Western blot using a mouse anti-Myc monoclonal antibody (Ab) and HRP-conjugated secondary antibody. GFP (as negative control), dimer of wild-type EL is 109,201 Da and of the dimer with the
EL, and EL-EL were expressed in HEK293 cells under conditions promoting differ- covalent linker is 110,061 Da. Both of the uncleaved preparaent levels of cleavage. HEK293 cells stably expressing profurin prevented EL tions gave highly similar decay functions, which indicated a
cleavage, and HEK293 cells stably expressing PC5a promote the cleavage of EL.
functional molecular mass of protein of 103.3 kDa for the
uncleaved wild-type EL and 108.5 kDa for the uncleaved dimer
media of cells expressing profurin, whereas wild-type EL and that contains the additional 8-amino acid linker. Thus we can
EL-EL dimer were more heavily cleaved in the presence of PC5a conclude that EL functions as a head-to-tail homodimer. The
expression. Interestingly, EL-EL appeared more resistant to wild-type EL that had undergone cleavage also gave a single
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TABLE 1
Triglyceride lipase and phospholipase activities of EL and EL-EL
under conditions promoting different levels of cleavage
Wild-type EL and EL-EL were expressed in HEK293 cells under control conditions
and under conditions promoting different levels of cleavage. HEK293 cells stably
expressing profurin prevent EL cleavage, and HEK293 cells stably expressing PC5a
promote the cleavage of EL. The triglyceride lipase activity (TG activity) and phospholipase activity (PL activity) of each conditioned medium were expressed in nanomoles of free fatty acid product (P) formed/h-ml of conditioned media as source of
lipase. The activity values reported in this table are the mean values and the standard
deviations (mean ⫾ S.D., n ⫽ 3). The ratio of the triglyceride lipase to phospholipase
activity (TG/PL ratio) represent the substrate specificity of the enzyme. The last
column represents the mean values and the mean ⫾ S.D. of the triglyceride/phospholipase ratios across independent experiments (n ⫽ 5 for HEK 293 cell media and
n ⫽ 4 each for cell media from HEK293 cells expressing profurin or PC5a). Statistical
analysis was run using an unpaired t test to determine whether the mean of the
triglyceride/phospholipase ratios were significantly different (p ⬍ 0.05). The triglyceride/phospholipase ratios of EL-EL and wild-type EL were not statistically different experimentally whatever the cell types used for the transfection.
Lipases

TG activity

PL activity

nmol P/h/ml

nmol P/h/ml

PC5a

EL
EL-EL
EL
EL-EL
EL
EL-EL

172.5 ⫾ 8.4
425.5 ⫾ 8.6
265.9 ⫾ 3.8
484.9 ⫾ 20.2
445.2 ⫾ 10.5
673.5 ⫾ 22.1

92.7 ⫾ 7.4
173.1 ⫾ 10.6
172.4 ⫾ 1.1
226.0 ⫾ 11.3
306.5 ⫾ 79.1
313.1 ⫾ 4.5

Profurin

TG/PL ratio
(mean ⴞ S.D.)
1.92 ⫾ 0.12
1.56 ⫾ 0.62
1.56 ⫾ 0.24
1.46 ⫾ 0.57
1.72 ⫾ 0.24
1.79 ⫾ 0.58

FIGURE 6. Radiation inactivation of EL and EL-EL. The loss of triglyceride
lipase activity of EL as a function of radiation dose (megarads) is shown.
Three sources of EL were studied as follows: conditioned medium from
cells expressing myc-His-tagged wild-type EL that was partially cleaved
(〫, wt(cleaved)), conditioned medium from cells expressing profurin to
produce EL that was uncleaved (⌬, wt(uncleaved)), and conditioned
medium from cells expressing profurin to produce EL-EL that was
uncleaved (䡺, dimer(uncleaved)).

exponential decay as a function of radiation dose that was
clearly different from the other two. The functional molecular
mass of protein calculated for that preparation was 79 kDa. The
predicted molecular masses of the protein components of partially cleaved forms are 90,629 and 82,629 Da, respectively
(these are the 108- and 96-kDa forms in Fig. 4A with carbohydrate). These data indicate that, after cleavage, one of the
domains can dissociate from the intact monomer, whereas the
other remains with the monomer and the molecule remains
active.
Structural Modeling of EL—Comparative models of EL were
created computationally to assess the feasibility of head-to-tail
homodimer formation with EL and the possible impact of such
a configuration on activity. Presently, no high resolution strucAUGUST 28, 2009 • VOLUME 284 • NUMBER 35

DISCUSSION
LPL, HL, and EL are members of the triglyceride lipase gene
subfamily involved in plasma lipoprotein metabolism. EL has a
particular tropism for HDL and modulates HDL metabolism in
mice and in humans (41, 42). To date, only the three-dimensional structure pancreatic lipase has been resolved by x-ray
crystallography (2). Based on the high amino acid homology
and the conservation of the catalytic triad, LPL, HL, and EL are
assumed to present three-dimensional structures similar to
pancreatic lipase. Both HL and LPL have been shown to be
active in a homodimeric form, using methods varying from
ultracentrifugation, gel filtration, antibody inhibition, to radiation inactivation (18, 21, 23, 24, 26 –28, 43). Mutants of LPL
engineered by molecular biology have shown that LPL is active
as a homodimer in a head-to-tail conformation (28 –30).
The purpose of this work was to determine the active form of
EL. Initial experiments of immunoprecipitation of media from
co-transfection of constructs encoding EL-myc and EL-FLAG
showed that proteins immunoprecipitated with anti-Myc antibody contained both Myc-tagged EL and FLAG-tagged EL.
Thus, there was an interaction between EL-FLAG and EL-myc
proteins, consistent with an oligomerization of EL. However,
when conditioned media from cells expressing either EL-myc
or EL-FLAG were incubated together prior to immunoprecipitation, no evidence of interaction was observed. This suggests
that dimerization occurs intracellularly, before secretion, and
that there is a high affinity, stable interaction between subunits.
Ultracentrifugation studies of other triglyceride lipase family
members suggested that the plasma compartment lipases are
dimers. Human HL was shown to have a molecular mass of 121
kDa (43), and similar studies of rat HL showed 113 kDa (26).
Together, these data suggested that HL exists as a dimer. Analysis of the sedimentation coefficient of bovine LPL yielded a
molecular weight of 96,900, whereas the molecular weight of
the monomer was 48,300 (21). Thus the native LPL enzyme
appears to be a dimer of presumably identical subunits. Similarly, the bovine LPL activity profiles from sedimentation equilibrium as well as from gel filtration indicated that activity was
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293 cells

tures of EL have been determined, in part due to the marginal
stability of the EL protein under laboratory conditions. Therefore, comparative modeling was employed to infer likely structures of the protein. Previously published structures of pancreatic lipases from human and horse were used as structural
templates in conjunction with multiple sequence alignments of
lipase sequences from several different species to generate
three-dimensional models of human EL monomers. After
model refinements using the MODELLER suite, the best scoring EL monomer models were aligned to the structure of the
horse pancreatic lipase, which crystallized as a head-to-tail
dimer (40). The EL dimer model (Fig. 7) aligns well to each
monomer within the horse pancreatic lipase dimer, and the
overall positions of the N terminus, activation lid, hinge, and
C-terminal domains are similar to those of horse pancreatic
lipase. The EL dimer model contains no steric clashes between
monomers at the dimer interface. Within the EL dimer model,
the N-terminal catalytic triad is in proximity (within 30 Å) to
the C-terminal domain of the other monomer.
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we made a construct encoding
such a dimer covalently linked by
an 8-amino acid hinge region (Fig.
1). The construct also contained a
myc-His tag to allow estimation of
expression. The dimer construct
expressed nearly as well as the wild
type. However, the triglyceride and
phospholipase activities of the
dimer preparations were consistently higher that those of the wild
type. The ratios of triglyceride to
phospholipase activities were essentially unchanged, indicating that the
covalent linkage of the dimer had no
effect on substrate specificity. To
determine the effect of cleavage on
activity, we compared activity from
wild type to that of the dimer in conditions of normal, high, or low activity of proprotein convertases. As
shown in Table 1, activity was highFIGURE 7. Molecular model of the EL dimer. Top view of the human endothelial lipase dimer model is shown. est in the absence of cleavage for
The N-terminal “head” domains are shaded in blue; the C-terminal “tail” domains are shaded in red. The activa- both wild-type and dimeric EL and
tion lid is colored green. The three catalytic residues, serine 169, aspartic acid 193, and histidine 274 are
rendered in a space-filling format and located under the activation lid. A collection of exposed hydrophobic lowest for both in the presence of
residues, Met-351, Leu-382, Pro-383, Ile-386, Val-387, Phe-398, Leu-399, Val-400, Pro-437, Pro-440, and Gly-441, the highest degree of cleavage.
is highlighted in pink on monomer 1. Monomer 2 is rendered so as to reveal the N- and C-terminal domains, Interestingly, the dimeric form
hinge, and secondary structure.
appeared to be more resistant to loss
of activity than the wild type. This
associated almost exclusively with the dimer fraction (24). may be due to a resistance to cleavage by proprotein convertaSucrose density gradient centrifugation was also used to deter- ses or to the fact that the covalent hinge between the C terminus
mine that monomeric LPL refolded in the presence of calcium of the original first EL monomer keeps the N terminus of the
second EL monomer attached so that an active molecule is
becomes dimeric (44).
A complicating issue in determining the functional size of retained. Even with a high degree of cleavage (Fig. 5) of EL
catalytically active EL relates to its susceptibility to proteolytic prepared in cells expressing PC5, robustly detectable activity
cleavage by proprotein convertases (19, 20). One can predict remains (Table 1), suggesting that fully cleaved N- and C-terthat, upon cleavage of a dimeric uncleaved EL, a number of minal fragments can remain together and maintain an active
possible forms might be obtained (Fig. 4A) and that some of site.
The functional size of EL was also examined using radiation
these partially cleaved forms could potentially retain catalytic
activity. The lack of enzymatic activity of the N-terminal por- inactivation to determine the size of the active unit. The radiation of EL (14) indicates that an interaction with the C-terminal tion inactivation method was developed to determine the size
domain is essential to activity. Even if EL is active as a dimer in of enzymes (45) and has been previously used to determine the
a head-to-tail conformation, other intermediate forms could functional molecular mass of both LPL (23, 46) and HL (25, 44).
potentially also be active as long as an intact active site is pres- For bovine milk LPL, the combined data of radiation inactivaent and the contribution of the C-terminal domain is preserved. tion under a number of different conditions yielded a functional
Using classic sucrose density ultracentrifugation methods, we size of 72 kDa for the unglycosylated protein, which is close to
compared the mobility of wild-type EL to that of several pro- that expected for a dimer, 77 kDa (23). For rat LPL the functeins of known molecular masses and calculated that the molec- tional molecular mass was calculated to be 127 kDa, again the
ular mass of wild-type EL was 94.5 kDa. As this preparation of unglycosylated size (46), consistent with a dimer. Thus the
EL was made in HEK293 cells, which also secrete proprotein smallest unit required for enzyme function constitutes a dimer
convertases, EL in the preparation was at least partially cleaved. in the case of LPL. There is some discrepancy in the literature
The estimated molecular mass is consistent with either of the with regard to the functional unit of HL. When recombinant
partially cleaved forms (Fig. 4A) where an intact N-terminal or human HL was subjected to radiation inactivation, the size of
C-terminal domain remains associated with an intact mono- functional HL was calculated to be 109 kDa (unglycosylated),
mer. These data suggest that one or both of these partially the size of a homodimer (43). An examination of rat HL from
liver, adrenal gland, and ovaries showed that the liver enzyme
cleaved forms is active.
We then prepared EL in a head-to-tail homodimer using had a functional molecular mass of 63 kDa (monomeric), but
methods similar to those used by Wong et al. (28), wherein the enzymes from the adrenals and ovaries both showed func-
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vertases, resulting in partially cleaved dimeric forms of EL that
retain some activity and could have particular physiologic roles.
Because EL is a pharmacologic target for inhibition as a strategy
to raise HDL cholesterol levels, detailed structural information
regarding the active forms of EL could be important to the
optimal design of EL inhibitors.
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tional molecular masses of 117 kDa (dimeric) (26). Unlike the
sucrose density analysis, radiation inactivation is not influenced
by glycosylation and might therefore be a more accurate
method in the case of glycosylated protein such as EL. Another
advantage to the radiation inactivation is that it is a method for
determining the functional size of a protein without the need of
prior purification. Uncleaved preparations of wild-type EL and
EL-EL gave similar functional molecular mass estimates, consistent with the concept that EL is active as a homodimer and
are in agreement with the data previously generated for LPL
(23, 46) and HL (25, 43). Interestingly, cleavage of only one
“side” of the homodimer results in an intermediate size form
(Fig. 4A) that is still active, although less so than the full
homodimer.
In an elegant model of LPL (47), a head-to-tail conformation
was proposed where the monomers associate side-by-side. This
conformation has enough space for the lid to move freely to
enable a conformational change upon substrate binding (47).
Based on this, we developed a similar model for EL (Fig. 7). Our
EL dimer model contains no steric clashes between monomers
at the dimer interface. Within this model, the N-terminal catalytic triad of one-half of the dimer is in close proximity to the
C-terminal domain of the other half. This model suggests how
the C-terminal domain could affect substrate specificity by
playing a role in positioning the substrate in proximity to the
catalytic triad of the other half of the dimer across the dimer
interface. In contrast, in a monomer model, the C-terminal
domain is almost twice as far from the catalytic triad (⬃60 Å).
Indeed in the EL dimer model, a hydrophobic collection of
amino acids (Met-351, Leu-382, Pro-383, Ile-386, Val-387, Phe398, Leu-399, Val-400, Pro-437, Pro-440, and Gly-441) in the
C-terminal domain is in proximity to the catalytic triad (under
the activation lid) of the N-terminal domain of the other monomer (Fig. 7). Furthermore, there is ample volume for the activation lids of each monomer to open into the middle part of the
dimer interface, and therefore head-to-tail packing could help
stabilize the opening of the lid through ionic or hydrophobic
interactions on the surface of the opposing monomer, similar to
the observations of Kobayashi et al. (29) with their computational model of LPL. These observations, in conjunction with
the biochemical activity data, suggest that head-to-tail dimerization of EL may help position the C-terminal domain, important for substrate specificity, in close proximity to the catalytic
region of the enzyme while in turn stabilizing the movement of
the activation lid.
In conclusion, HL and LPL have been shown using a variety
of methods to be active in a homodimeric form and, at least for
LPL, in a head-to-tail conformation. We comprehensively studied EL functional size using a variety of similar methods, including ultracentrifugation, radiation inactivation, covalent EL
homodimer, immunoprecipitation, and molecular modeling.
Our data are wholly consistent with a model in which EL oligomerizes into a homodimer that is active in a head-to-tail conformation. Only the full length of EL is present on the cell surface (data not shown), and it is conceivable that dimerization of
EL allows its optimal activity against and interaction with its
substrates, HDL, on the endothelial surface. Furthermore, EL is
proteolytically cleaved in the hinge region by proprotein con-
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